Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma
Pablo E. Serrano, Joseph M. Herman, Kent A. Griffith, Mark M. Zalupski, Edward J. Kim, Tanios S. Bekaii-Saab, Edgar Ben-Josef, Laura A. Dawson, Jolie Ringash, Alice C. Wei
Dive into the research topics of 'Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma'. Together they form a unique fingerprint.